Genentech to Present Significant Progress in Advanced Skin, Lung and Ovarian Cancers at ASCO | Business Wire
Links shared publicly online about this topic.
- 284total visits
Genentech to Present Significant Progress in Advanced Skin, Lung and Ovarian Cancers at ASCO | Business Wire
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that data showing new personalized approaches for people with ski
View full resource at businesswire.com
Tags: Skin, Cancer, Ovarian Cancer, Lung, Women's Health, Roche Pharmaceuticals, Genentech
Most Recently Shared on May 18, 2011 at 9:52 am By:
Genentech to Present Significant Progress in Advanced Skin, Lung and Ovarian Cancers at ASCO: SOUTH SAN FRANCISC... http://bit.ly/itGf7e
Advertisement
